Vitalik Buterin's Unwanted Shiba Inu Windfall Funds COVID Vaccine Trial
Key Summary
Ethereum co-founder Vitalik Buterin's Shiba Inu tokens, received without his consent, are funding a COVID-19 vaccine trial. The vaccine, developed by PopVax, will be open-sourced and made available for anyone to improve and manufacture without a license. Meanwhile, Shiba Inu's price is struggling, down 4.33% in 24 hours, despite the team's optimism about early breakout signals.
Background Context
Copper and aluminum prices retreated on October 13, 2026, due to growing concerns about AI spending and infrastructure financing. The South Korea equity benchmark fell 7% during the same period.
Ethereum co-founder Vitalik Buterin has helped bankroll a COVID-19 vaccine now in human trials. The millions behind it trace back to Shiba Inu (SHIB) tokens he never asked to receive.
SHIB itself, however, is struggling. The meme coin has dropped 4.33% in 24 hours, yet the Shiba Inu team says it shows early signs of a breakout.
How a Shiba Inu Windfall Reached a Vaccine Lab
The vaccine was developed by PopVax, a biotech startup based in Hyderabad, India. Balvi, Vitalik Buterin's science fund, and the Gates Foundation put $20 million into the program. The startup says Balvi's money came from Shiba Inu tokens sent to Buterin without his consent.
The Shiba Inu team says forced selling within crypto deepened the drop. In its view, this pattern typically appears when heavy leverage meets a pullback.
Meanwhile, the meme coin that seeded Balvi's vaccine money is under pressure. The team says forced selling within crypto deepened the drop.
Can SHIB Shake Off Leverage and Break Out?
The losses stretch beyond a single day. BeInCrypto's Shiba Inu price page shows SHIB down 9.64% over the past seven days.
The Shiba Inu team argues that the market is turning bullish again. It adds that SHIB is flashing early breakout signals.
Ultimately, Buterin's vaccine bet shows how unsolicited Shiba Inu wealth can fund open science. Similar money now backs crypto's longevity bet, too. That legacy may outlast any single SHIB breakout.